- Home
- PMN vs GROW Comparison
PMN vs GROW Comparison
Compare PMN & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- GROW
- Stock Information
- Founded
- PMN 2004
- GROW 1968
- Country
- PMN Canada
- GROW United States
- Employees
- PMN N/A
- GROW N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- GROW Investment Managers
- Sector
- PMN Health Care
- GROW Finance
- Exchange
- PMN Nasdaq
- GROW Nasdaq
- Market Cap
- PMN 32.3M
- GROW 33.9M
- IPO Year
- PMN N/A
- GROW N/A
- Fundamental
- Price
- PMN $0.98
- GROW $2.39
- Analyst Decision
- PMN
- GROW
- Analyst Count
- PMN 0
- GROW 0
- Target Price
- PMN N/A
- GROW N/A
- AVG Volume (30 Days)
- PMN 89.7K
- GROW 79.5K
- Earning Date
- PMN 11-26-2024
- GROW 11-07-2024
- Dividend Yield
- PMN N/A
- GROW 3.76%
- EPS Growth
- PMN N/A
- GROW N/A
- EPS
- PMN N/A
- GROW 0.12
- Revenue
- PMN N/A
- GROW $10,008,000.00
- Revenue This Year
- PMN N/A
- GROW N/A
- Revenue Next Year
- PMN N/A
- GROW N/A
- P/E Ratio
- PMN N/A
- GROW $19.77
- Revenue Growth
- PMN N/A
- GROW N/A
- 52 Week Low
- PMN $0.92
- GROW $2.38
- 52 Week High
- PMN $3.10
- GROW $3.11
- Technical
- Relative Strength Index (RSI)
- PMN 42.82
- GROW 40.48
- Support Level
- PMN $0.97
- GROW $2.43
- Resistance Level
- PMN $1.08
- GROW $2.53
- Average True Range (ATR)
- PMN 0.13
- GROW 0.06
- MACD
- PMN -0.00
- GROW -0.00
- Stochastic Oscillator
- PMN 1.67
- GROW 0.00
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.